Pharmaceutical Combination comprising rilpivirine HCl, emtricitabine and tenofovir disoproxil fumarate

摘要

Refers to a combination in the form of Tablet comprises a First layer and a second layer. The First Layer includes; (a) The rilpivirine HCl and is substantially free of tenofovir disoproxil fumarate; (b) the second layer comprising tenofovir disoproxil fumarate and this sustancialme Nte Free rilpivirine HCl; and (c) The Tablet also includes emtricitabine.The pharmaceutical combination is useful in the treatment of Viral Infections such as HIV